+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

Infant Nutrition Hydrolysate Ingredients - Global Strategic Business Report

  • PDF Icon

    Report

  • 374 Pages
  • July 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 6106637
The global market for Infant Nutrition Hydrolysate Ingredients was estimated at US$81.6 Billion in 2024 and is projected to reach US$121.2 Billion by 2030, growing at a CAGR of 6.8% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Infant Nutrition Hydrolysate Ingredients market.

Global Infant Nutrition Hydrolysate Ingredients Market - Key Trends & Drivers Summarized

Why Is Demand for Hydrolysate-Based Ingredients Rising in Infant Nutrition?

The demand for hydrolysate-based ingredients in infant nutrition is rising sharply due to a combination of medical necessity, parental awareness, and advancements in nutritional science. Hydrolysates, which are proteins broken down into smaller peptides and amino acids, are used in infant formulas to support better digestion and reduce allergenic responses. This form of protein modification makes them particularly valuable for infants who are unable to tolerate intact cow's milk protein, a condition that affects a growing number of newborns worldwide. Parents are increasingly turning to hydrolyzed formulas as a first-line preventive measure, not only for managing cow's milk protein allergy but also for addressing other gastrointestinal issues such as colic, reflux, and feeding intolerance. The increasing recognition of the early-life gut microbiome's influence on long-term health is also influencing consumer choices, with hydrolysate-based products perceived as gentler and more supportive of healthy gut development. Additionally, rising rates of cesarean births, reduced breastfeeding durations, and increased incidence of atopic conditions like eczema and asthma in infants have contributed to the clinical recommendation and use of hydrolyzed formulas. Pediatricians and dietitians often advocate for partially or extensively hydrolyzed proteins based on an infant's risk profile or symptoms. As infant formula becomes more specialized and segmented, manufacturers are responding by developing formulations that cater to specific allergy prevention and management needs, positioning hydrolysates as a premium and functional ingredient. With increasing global awareness around food sensitivities and a stronger emphasis on early intervention for lifelong health, hydrolysate ingredients are becoming central to innovation in the infant nutrition space.

Can Scientific Advances Improve the Efficacy and Acceptance of Hydrolysate Ingredients?

Scientific advances are playing a transformative role in improving both the functional efficacy and sensory acceptance of hydrolysate ingredients in infant nutrition. One of the primary challenges historically associated with hydrolyzed proteins has been their bitter taste and off-putting odor, which can lead to poor feeding compliance among infants and create hesitancy among caregivers. Innovations in enzymatic hydrolysis processes are addressing this issue by allowing more precise control over peptide length and composition, which directly influences taste and nutritional quality. Additionally, selective hydrolysis techniques are being developed to retain key bioactive peptides that offer immune-modulating and gut-protective benefits while minimizing allergenic epitopes. These improvements are leading to formulations that are not only safer for allergy-prone infants but also more palatable, increasing their acceptance and adherence. Advanced protein purification and masking technologies are also being employed to neutralize unpleasant sensory characteristics, making hydrolysate-based formulas more competitive with standard formulas in taste and texture. Clinical studies continue to support the benefits of hydrolysates in reducing the risk of allergy development, particularly in high-risk infants with a family history of atopic conditions. Further, research into the peptide profiles of breast milk is guiding the development of hydrolysates that mimic human milk more closely, enhancing their functional compatibility with infant biology. These innovations are helping brands bridge the gap between clinical performance and consumer appeal, expanding the potential market for hydrolysate-based formulas. As science deepens our understanding of early-life immune and digestive development, hydrolysate ingredients are expected to become even more targeted and effective, solidifying their role in next-generation infant nutritional products.

How Are Market Dynamics and Consumer Trends Influencing Ingredient Innovation?

The market for infant nutrition hydrolysate ingredients is being shaped by a dynamic interplay of consumer demand, regulatory change, and competitive differentiation. Health-conscious millennial and Gen Z parents are seeking transparency, safety, and science-backed benefits in infant formula, driving demand for hypoallergenic and functional ingredients. These consumer expectations are influencing manufacturers to adopt clean-label practices, even in specialized products such as hydrolysate-based formulas. There is increasing emphasis on sourcing traceable, high-quality raw materials, including whey and casein proteins from hormone-free, grass-fed dairy herds. Moreover, plant-based alternatives to traditional dairy-derived hydrolysates are being explored, reflecting broader shifts toward sustainability and vegan nutrition trends, though these remain limited in infant applications due to regulatory and nutritional constraints. Another key driver is the growing demand in Asia-Pacific, Latin America, and the Middle East, where urbanization, rising disposable incomes, and changing family structures are leading to increased formula use, including specialty formulas. Market leaders are differentiating themselves through proprietary hydrolysis processes and clinically validated peptide profiles, often backed by research partnerships with pediatric institutions. In parallel, the regulatory landscape is becoming more supportive of innovation while maintaining high safety standards. Updated guidelines from entities such as the European Food Safety Authority and the U.S. FDA are clarifying requirements for hypoallergenic labeling and clinical substantiation. Companies are responding with robust clinical trials and investments in ingredient research to ensure compliance and market acceptance. E-commerce and direct-to-consumer platforms are further accelerating product innovation by providing data-driven insights into consumer behavior, preferences, and feedback. Together, these market forces are fostering a highly innovative environment where ingredient suppliers and formula manufacturers are aligning to deliver safer, more effective, and more appealing hydrolysate-based infant nutrition solutions.

What Factors Are Driving the Accelerated Growth of the Hydrolysate Ingredient Segment?

The growth in the infant nutrition hydrolysate ingredients market is driven by several key factors rooted in medical demand, consumer behavior, and technological advancement. One of the most critical drivers is the rising global incidence of cow's milk protein allergy and related feeding disorders in infants, necessitating safer and more digestible formula options. This is being complemented by increasing awareness among parents and pediatricians about the potential long-term benefits of early dietary interventions in reducing allergy risk and supporting immune development. The trend toward delayed breastfeeding and the growing reliance on formula feeding, particularly in dual-income households, is further amplifying demand for specialized products like hydrolysate formulas that can serve as both preventive and therapeutic nutritional tools. Technological advancements in protein processing, flavor masking, and peptide profiling are also enabling the creation of more effective and better-tasting hydrolysate ingredients, enhancing consumer acceptance and broadening their appeal. Strategic investments by key players in clinical trials and pediatric research are strengthening the scientific credibility of hydrolysate products, reinforcing their market position in both standard and medical nutrition segments. Moreover, the expansion of retail distribution channels and online platforms is improving accessibility to specialized formulas, particularly in emerging markets where medical guidance and product availability were historically limited. Supportive policy environments, including national health programs and insurance coverage for hypoallergenic formulas in some regions, are also contributing to market expansion. Lastly, heightened interest in personalized nutrition and the gut-immune connection in early life is encouraging further research and innovation in this space. These combined factors are creating a robust growth trajectory for hydrolysate ingredients in infant nutrition, positioning them as a cornerstone of modern pediatric dietary solutions.

Scope Of Study:

The report analyzes the Infant Nutrition Hydrolysate Ingredients market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments: Ingredient Type (General Pediatric Types, Pediatric FSMP Types); Form (Powder Form, Liquid Form); Application (Below 6 Months Application, 6-12 Months Application, Above 12 Months Application, Food for Special Medical Purposes Application)

Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the General Pediatric Types segment, which is expected to reach US$78.6 Billion by 2030 with a CAGR of a 8.1%. The Pediatric FSMP Types segment is also set to grow at 4.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $22.2 Billion in 2024, and China, forecasted to grow at an impressive 10.9% CAGR to reach $25.5 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Infant Nutrition Hydrolysate Ingredients Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Infant Nutrition Hydrolysate Ingredients Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Infant Nutrition Hydrolysate Ingredients Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as Abbott Laboratories, Agropur, Arla Foods, Armor Protéines, Ausnutria Dairy Corporation Ltd. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 44 companies featured in this Infant Nutrition Hydrolysate Ingredients market report include:

  • Abbott Laboratories
  • Agropur
  • Arla Foods
  • Armor Protéines
  • Ausnutria Dairy Corporation Ltd.
  • BASF SE
  • Bunge Limited
  • Carbery Group
  • Danone SA
  • Fonterra Co-operative Group Ltd
  • FrieslandCampina
  • Glanbia PLC
  • Hilmar Cheese Company
  • Ingredion Incorporated
  • Kerry Group
  • Mead Johnson Nutrition (Reckitt)
  • Nestlé S.A.
  • Royal DSM (now DSM-Firmenich)
  • Tatua Co-operative Dairy Company
  • Valio Ltd.

This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:

  • Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
  • Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
  • Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
  • Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
  • Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
  • Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
  • Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Tariff Impact on Global Supply Chain Patterns
  • Infant Nutrition Hydrolysate Ingredients - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Incidence of Infant Food Allergies and Intolerances Throws the Spotlight on Hydrolysate Ingredients in Specialized Nutrition
  • Growth in Demand for Hypoallergenic and Gentle Formulas Propels Use of Partially and Extensively Hydrolyzed Proteins
  • Here`s the Story: Pediatric Recommendations and Clinical Guidelines Strengthen the Business Case for Hydrolysate-Based Infant Nutrition
  • Increasing Consumer Awareness of Gut Health and Early-Life Immunity Drives Adoption of Hydrolysate Ingredients in Infant Formulas
  • Expansion of Lactose-Free and CMPA (Cow`s Milk Protein Allergy) Product Lines Fuels Formulation Demand for Hydrolyzed Whey and Casein
  • Here`s How Advances in Enzymatic Hydrolysis Are Enabling Precision Control of Peptide Size and Allergenicity
  • Rising Demand for Clean Label and Science-Backed Claims Spurs Development of Mild Processing and Traceable Ingredient Sourcing
  • Global Growth in Premature and Low Birth Weight Infant Populations Expands Use of Hydrolysate-Enhanced Medical Nutrition Products
  • Integration of Prebiotics, Probiotics, and Hydrolysates Supports Multifunctional Formulas in Premium Infant Nutrition Segments
  • E-Commerce and Parental Engagement Platforms Boost Visibility and Education Around Hydrolysate-Based Formulas
4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Infant Nutrition Hydrolysate Ingredients Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • TABLE 2: World Recent Past, Current & Future Analysis for Infant Nutrition Hydrolysate Ingredients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 3: World Historic Review for Infant Nutrition Hydrolysate Ingredients by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 4: World 16-Year Perspective for Infant Nutrition Hydrolysate Ingredients by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
  • TABLE 5: World Recent Past, Current & Future Analysis for General Pediatric Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 6: World Historic Review for General Pediatric Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 7: World 16-Year Perspective for General Pediatric Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 8: World Recent Past, Current & Future Analysis for Pediatric FSMP Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 9: World Historic Review for Pediatric FSMP Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 10: World 16-Year Perspective for Pediatric FSMP Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 11: World Recent Past, Current & Future Analysis for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 12: World Historic Review for Powder Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 13: World 16-Year Perspective for Powder Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 14: World Recent Past, Current & Future Analysis for Liquid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 15: World Historic Review for Liquid Form by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 16: World 16-Year Perspective for Liquid Form by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 17: World Recent Past, Current & Future Analysis for Below 6 Months Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 18: World Historic Review for Below 6 Months Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 19: World 16-Year Perspective for Below 6 Months Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 20: World Recent Past, Current & Future Analysis for 6-12 Months Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 21: World Historic Review for 6-12 Months Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 22: World 16-Year Perspective for 6-12 Months Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 23: World Recent Past, Current & Future Analysis for Above 12 Months Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 24: World Historic Review for Above 12 Months Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 25: World 16-Year Perspective for Above 12 Months Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
  • TABLE 26: World Recent Past, Current & Future Analysis for Food for Special Medical Purposes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • TABLE 27: World Historic Review for Food for Special Medical Purposes Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2023 and % CAGR
  • TABLE 28: World 16-Year Perspective for Food for Special Medical Purposes Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Infant Nutrition Hydrolysate Ingredients Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Abbott Laboratories
  • Agropur
  • Arla Foods
  • Armor Protéines
  • Ausnutria Dairy Corporation Ltd.
  • BASF SE
  • Bunge Limited
  • Carbery Group
  • Danone SA
  • Fonterra Co-operative Group Ltd
  • FrieslandCampina
  • Glanbia PLC
  • Hilmar Cheese Company
  • Ingredion Incorporated
  • Kerry Group
  • Mead Johnson Nutrition (Reckitt)
  • Nestlé S.A.
  • Royal DSM (now DSM-Firmenich)
  • Tatua Co-operative Dairy Company
  • Valio Ltd.

Table Information